Jonathan H. Ward
About
Jonathan H. Ward is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery.
According to data from OpenAlex, Jonathan H. Ward has authored 30 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Jonathan H. Ward's work include Heart Failure Treatment and Management (24 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiac pacing and defibrillation studies (11 papers). Jonathan H. Ward is often cited by papers focused on Heart Failure Treatment and Management (24 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiac pacing and defibrillation studies (11 papers). Jonathan H. Ward collaborates with scholars based in United States, Canada and Norway. Jonathan H. Ward's co-authors include Scott D. Solomon, Kristin Williamson, Akshay S. Desai, Robert J. Mentz, Margaret F. Prescott, David A. Morrow, Eric J. Velazquez, Shelley Zieroth, Adrian F. Hernandez and Randall C. Starling and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.
In The Last Decade
Jonathan H. Ward
22 papers receiving 305 citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jonathan H. Ward United States | 10 | 283 | 67 | 56 | 28 | 13 | 30 | 311 | ||
| Matthieu Pannaux France | 5 | 259 0.9× | 62 0.9× | 48 0.9× | 14 0.5× | 16 1.2× | 6 | 302 | ||
| Cheryl Abbas United States | 7 | 312 1.1× | 68 1.0× | 64 1.1× | 81 2.9× | 17 1.3× | 15 | 389 | ||
| Jan Wintrich Germany | 9 | 256 0.9× | 45 0.7× | 36 0.6× | 33 1.2× | 18 1.4× | 24 | 302 | ||
| C. B. Granger United States | 7 | 280 1.0× | 43 0.6× | 35 0.6× | 38 1.4× | 12 0.9× | 23 | 324 | ||
| Vanja Vlajnic United States | 5 | 199 0.7× | 44 0.7× | 26 0.5× | 10 0.4× | 31 2.4× | 6 | 226 | ||
| Aristi Boulmpou Greece | 10 | 132 0.5× | 76 1.1× | 23 0.4× | 53 1.9× | 31 2.4× | 49 | 251 | ||
| Eva Turgonyi United Kingdom | 9 | 130 0.5× | 48 0.7× | 24 0.4× | 22 0.8× | 15 1.2× | 12 | 190 | ||
| Adriaan A. Voors Netherlands | 6 | 137 0.5× | 75 1.1× | 47 0.8× | 33 1.2× | 32 2.5× | 31 | 185 | ||
| Daniel N. Silverman United States | 9 | 318 1.1× | 38 0.6× | 33 0.6× | 33 1.2× | 11 0.8× | 24 | 359 | ||
| Sophia Emmons‐Bell United States | 4 | 147 0.5× | 18 0.3× | 36 0.6× | 22 0.8× | 35 2.7× | 5 | 245 |
Countries citing papers authored by Jonathan H. Ward
Since
Specialization
Citations
This map shows the geographic impact of Jonathan H. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan H. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan H. Ward more than expected).
Fields of papers citing papers by Jonathan H. Ward
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jonathan H. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan H. Ward. The network helps show where Jonathan H. Ward may publish in the future.
Co-authorship network of co-authors of Jonathan H. Ward
This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan H. Ward. A scholar is included among the top collaborators of Jonathan H. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan H. Ward. Jonathan H. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Maron, David J., Paul A. Heidenreich, Shriram Nallamshetty, et al.. (2025). Lipoprotein a Testing Patterns in the Veterans Health Administration. JAMA Network Open. 8(1). e2453300–e2453300.
2.
Gunn, Alexander, Derek D. Cyr, Adrian F. Hernandez, et al.. (2025). Sacubitril/Valsartan Versus Valsartan Initiation in Patients Naïve to Renin–angiotensin System Inhibitors: Insights from PARAGLIDE-HF. European Journal of Heart Failure. 27(8). 1418–1425.
3.
Peters, Anthony E., Shuang Li, Derek D. Cyr, et al.. (2025). Influence of ejection fraction on outcomes with sacubitril/valsartan in patients with worsening heart failure with EF>40%: The PARAGLIDE-HF Trial. American Heart Journal. 289. 158–167.
4.
Kittipibul, Veraprapas, Derek D. Cyr, Josephine Harrington, et al.. (2025). Structural abnormalities and effects of sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: The PARAGLIDE-HF trial. American Heart Journal. 289. 105–116.
5.
Lee, Sahmin, Brian Claggett, James C. Fang, et al.. (2025). Changes in Cardiac Structure and Function are Associated with Health-Related Quality of Life in Heart Failure Patients with Reduced Ejection Fraction: Results from the EVALUATE-HF trial. European Journal of Heart Failure. 27(11). 2582–2593.
6.
Shoji, Satoshi, Derek D. Cyr, Adrian F. Hernandez, et al.. (2024). Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HF. American Heart Journal. 280. 70–78.
7.
Harrington, Josephine, Robert J. Mentz, Kirkwood F. Adams, et al.. (2024). Abstract 4140480: The Relationship Between Obesity Status and Change in NT-proBNP with Angiotensin-Neprilysin Inhibition in Patients with Mildly Reduced or Preserved Ejection Fraction and Recent Worsening Heart Failure Event: Results from the PARAGLIDE-HF Trial. Circulation. 150(Suppl_1).
8.
Morrow, David A., Eric J. Velazquez, Akshay S. Desai, et al.. (2024). Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure. Journal of the American College of Cardiology. 83(12). 1123–1132.
9.
Fudim, Marat, Derek D. Cyr, Jonathan H. Ward, et al.. (2024). Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial. Journal of Cardiac Failure. 30(12). 1568–1577.
10.
Omar, Alaa Mabrouk Salem, Sean Murphy, G. Michael Felker, et al.. (2023). Isovolumic Contraction Velocity in Heart Failure With Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study. Journal of Cardiac Failure. 30(5). 653–665.
11.
Vaduganathan, Muthiah, Robert J. Mentz, Brian Claggett, et al.. (2023). Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF. European Heart Journal. 44(31). 2982–2993.
12.
Myhre, Peder L., Yuxi Liu, Ian J. Kulac, et al.. (2023). Changes in Mid-Regional Pro-Adrenomedullin During Treatment with Sacubitril/Valsartan. European Journal of Heart Failure. 25(8). 1396–1405.
13.
Mentz, Robert J., Jonathan H. Ward, Adrian F. Hernandez, et al.. (2023). Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event. Journal of Cardiac Failure. 29(6). 922–930.
14.
Mohebi, Reza, Yuxi Liu, Javed Butler, et al.. (2023). Importance of the ‘Area Under the Curve’ from Serial NT-proBNP Measurements During Treatment with Sacubitril/Valsartan. ESC Heart Failure. 10(5). 3133–3140.
15.
Mentz, Robert J., Jonathan H. Ward, Adrian F. Hernandez, et al.. (2023). Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure. Journal of the American College of Cardiology. 82(1). 1–12.
16.
Mohebi, Reza, Yuxi Liu, Ileana L. Piña, et al.. (2022). Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction. Journal of the American College of Cardiology. 80(16). 1529–1541.
17.
Myhre, Peder L., Margaret F. Prescott, Sean Murphy, et al.. (2022). Early B-Type Natriuretic Peptide Change in HFrEF Patients Treated With Sacubitril/Valsartan. JACC Heart Failure. 10(2). 119–128.
18.
Myhre, Peder L., Brian Claggett, Amil M. Shah, et al.. (2022). Changes in cardiac biomarkers in association with alterations in cardiac structure and function, and health status in heart failure with reduced ejection fraction: the EVALUATE‐HF trial . European Journal of Heart Failure. 24(7). 1200–1208.
19.
Murphy, Sean, Margaret F. Prescott, Alan Maisel, et al.. (2021). ASSOCIATION BETWEEN ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION, CARDIOVASCULAR BIOMARKERS AND CARDIAC REMODELING IN HEART FAILURE WITH REDUCED EJECTION FRACTION. Journal of the American College of Cardiology. 77(18). 610–610.
20.
Khan, Muhammad Shahzeb, G. Michael Felker, Ileana L. Piña, et al.. (2020). Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes. JACC Heart Failure. 9(2). 137–145.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Matthieu Pannaux Breakdown of academic impact, for papers by Cheryl Abbas Breakdown of academic impact, for papers by Jan Wintrich Breakdown of academic impact, for papers by C. B. Granger Breakdown of academic impact, for papers by Vanja Vlajnic Breakdown of academic impact, for papers by Aristi Boulmpou Breakdown of academic impact, for papers by Eva Turgonyi Breakdown of academic impact, for papers by Adriaan A. Voors Breakdown of academic impact, for papers by Daniel N. Silverman Breakdown of academic impact, for papers by Sophia Emmons‐Bell